In Vitro Replication Inhibitory Activity of Xanthorrhizol against Severe Acute Respiratory Syndrome Coronavirus 2

In Vitro Replication Inhibitory Activity of Xanthorrhizol against Severe Acute Respiratory Syndrome Coronavirus 2

In spite of the large number of repositioned drugs and direct-acting antivirals in clinical trials for the management of the ongoing COVID-19 pandemic, there are few cost-effective therapeutic options for severe acute respiratory syndrome (SARS) coronavirus 2 (SCoV2) infection. In this paper, we sho...

Full description

Bibliographic Details
Main Authors: Minwoo Kim, Hee Cho, Dae-Gyun Ahn, Hae-Gwang Jung, Han Young Seo, Ji-Su Kim, Youn-Jung Lee, Jun Yong Choi, In Ho Park, Jeon-Soo Shin, Seong-Jun Kim, Jong-Won Oh
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Biomedicines
Subjects:
SARS-CoV-2
xanthorrhizol
pan-coronavirus antivirals
herbal medicine
SARS-CoV-1
human coronavirus
Online Access:https://www.mdpi.com/2227-9059/9/11/1725

Internet

https://www.mdpi.com/2227-9059/9/11/1725

Similar Items